![Richard Schwartz](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Richard Schwartz
Keine laufenden Positionen mehr
Profil
Richard Schwartz worked as Senior Director-Processing & Manufacturing Science at MedImmune Vaccines, Inc. from 2005 to 2008.
He then worked as Chief-Vaccine Production Program at Vaccine Research Center.
Later, he worked as Senior Vice President-Process Development at Synlogic, Inc. and as Senior Vice President-Technical Operations at Vaxart, Inc. In 2018-2019, he was Head-Technical Operations at CRISPR Therapeutics AG.
Dr. Schwartz received his undergraduate, graduate, and doctorate degrees from the University of Michigan.
Ehemalige bekannte Positionen von Richard Schwartz
| Unternehmen | Position | Ende |
|---|---|---|
| CRISPR THERAPEUTICS AG | Technik-/Wissenschafts-/F&E-Leiter | 01.10.2019 |
MedImmune Vaccines, Inc.
 MedImmune Vaccines, Inc. BiotechnologyHealth Technology Develops, manufactures and markets live vaccines | Corporate Officer/Principal | 01.05.2008 |
Vaccine Research Center | Corporate Officer/Principal | - |
| VAXART, INC. | Technik-/Wissenschafts-/F&E-Leiter | - |
| SYNLOGIC, INC. | Corporate Officer/Principal | - |
Ausbildung von Richard Schwartz
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
10
Beziehungen ersten Grades
6
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 6 |
|---|---|
MedImmune Vaccines, Inc.
MedImmune Vaccines, Inc. BiotechnologyHealth Technology Develops, manufactures and markets live vaccines | Health Technology |
University of Michigan
 University of Michigan Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Vaccine Research Center | |
CRISPR Therapeutics AG
 CRISPR Therapeutics AG BiotechnologyHealth Technology Develops gene-based medicines | Health Technology |
Synlogic, Inc.
 Synlogic, Inc. Financial ConglomeratesFinance Operates as a shell company | Finance |
Vaxart, Inc.
 Vaxart, Inc. BiotechnologyHealth Technology Develops vaccines | Health Technology |
